ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,022.57
0.18%
Dow Jones
38,703.27
-2.60%
Gold vs US Dollar
2,411.835
0.27%
Brent Oil
76.645
-0.67%
Bitcoin
55,123.49
2.10%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/08/202412:07PR Newswire (US)MITSUBISHI MOTORS: WHAT'S NEW FOR 2025
06/08/202412:03Alliance NewsAlliance NewsUK PM Keir Starmer pledges to "strengthen even more" Oman-UK relations
06/08/202412:02PR Newswire (US)Shutterstock Reports Second Quarter 2024 Financial ResultsNYSE:SSTKShutterstock Inc
06/08/202412:02PR Newswire (US)Skilled trades tech and sales expert Strickland Tudor joins GlassHouse Board of Advisors
06/08/202412:01Alliance NewsAlliance NewsLONDON MARKET MIDDAY: Markets stage recovery after Monday's sell-off
06/08/202412:01UK RegulatoryBlackRock Frontiers Investment Trust Plc - Net Asset Value(s)LSE:BRFIBlackrock Frontiers Investment Trust Plc
06/08/202412:00UK RegulatoryOKYO Pharma Granted European Patent Covering OK-101 Chemerin Analogs and Their Method of UseLSE:OKYOOkyo Pharma Limited
06/08/202412:00PR Newswire (US)Duke Energy reports second-quarter 2024 financial resultsNYSE:DUKDuke Energy Corp New
06/08/202412:00PR Newswire (US)National Renewable Solutions Announces Promotions to Expand its Executive Leadership
06/08/202412:00PR Newswire (US)Main Street Announces Fourth Quarter 2024 Regular Monthly Dividends and Supplemental Dividend Payable in September 2024NYSE:MAINMain Street Capital Corp
06/08/202412:00PR Newswire (US)Celebrated New Children's Book "A Tall Tale: How the Ostriches Got Their Long Necks and Long Legs" Promotes Lessons of Compromise and Collaboration
06/08/202412:00PR Newswire (US)Samsung Biologics joins the Pharmaceutical Supply Chain Initiative as Supplier Partner
06/08/202412:00UK RegulatoryBlackRock Income and Growth Investment Trust Plc - Net Asset Value(s)LSE:BRIGBlackrock Income And Growth Investment Trust Plc
06/08/202412:00UK RegulatoryBlackRock Smaller Companies Trust Plc - Net Asset Value(s)LSE:BRSCBlackrock Smaller Co Trust Plc
06/08/202412:00PR Newswire (US)Move This World Gets Added to CASEL Program Guide and Expands with New and Existing School District Partners
06/08/202412:00PR Newswire (US)Starwood Property Trust Reports Results for Quarter Ended June 30, 2024NYSE:STWDStarwood Property Trust Inc
06/08/202412:00PR Newswire (US)Broadridge Reports Fourth Quarter and Fiscal 2024 ResultsNYSE:BRBroadridge Financial Solutions Inc
06/08/202412:00PR Newswire (US)Former Silk Road 2.0 Operator Blake Benthall Launches Blockchain Analysis and Risk Management Startup Fathom(x)
06/08/202412:00PR Newswire (US)Elevation Oncology Announces Promising Initial Data from Phase 1 Clinical Trial Evaluating EO-3021 in Patients with Advanced Unresectable or Metastatic Solid Tumors Likely to Express Claudin 18.2NASDAQ:ELEVElevation Oncology Inc
06/08/202412:00PR Newswire (US)Symbiotic Capital, a First-of-its-Kind Life Science Credit Firm, Launches with More than $600 Million Raised
06/08/202412:00PR Newswire (US)Compugen Reports Second Quarter 2024 ResultsNASDAQ:CGENCompugen Ltd
06/08/202412:00PR Newswire (US)Galvanize Therapeutics Completes Enrollment in Clinical Trial Evaluating Aliya® Pulsed Electric Field (PEF) System for Late-Stage Non-Small Cell Lung Cancer and Metastasis to the Lung
06/08/202412:00PR Newswire (US)Nob Hill Therapeutics Secures Series A Funding to Advance Breakthrough Respiratory Technologies
06/08/202412:00PR Newswire (US)BMO Launches Enhanced Premium Rewards Credit Card with Mastercard to Help Customers Make Real Financial ProgressTSX:BMOBank of Montreal
06/08/202412:00PR Newswire (US)Murf Electric Bikes Unveils Redesigned Izzy Step-Thru
06/08/202412:00PR Newswire (US)BMO Launches Enhanced Premium Rewards Credit Card with Mastercard to Help Customers Make Real Financial ProgressNYSE:BMOBank of Montreal
06/08/202412:00PR Newswire (US)Arbe Announces Q2 2024 Financial ResultsNASDAQ:ARBEArbe Robotics Ltd
06/08/202412:00PR Newswire (US)HAMILTON LANE INCORPORATED REPORTS FIRST QUARTER FISCAL 2025 RESULTS, WITH MANAGEMENT & ADVISORY FEES GROWING BY 33% AND ASSETS UNDER MANAGEMENT GROWING BY 11% YEAR-OVER-YEARNASDAQ:HLNEHamilton Lane Inc
06/08/202412:00PR Newswire (US)Apple Tree Partners Launches Red Queen Therapeutics to Bring Potentially Lifesaving Treatments to People at Greatest Risk from Viral Infections
06/08/202412:00PR Newswire (US)Hagerty Reports Second Quarter 2024 ResultsNYSE:HGTYHagerty Inc

Your Recent History

LSE
GDR
Genedrive
LSE
AAZ
Anglo Asian Mining
LSE
HE1
Helium One Global
LSE
POS
Plexus
LSE
PANR
Pantheon Resources
LSE
LLOY
Lloyds Banking
LSE
LGEN
Legal & General
LSE
ENET
Ethernity Networks
LSE
UKOG
Uk Oil & Gas
LSE
THG
Thg
LSE
CGH
Chaarat Gold
LSE
BOO
Boohoo
LSE
SCLP
Scancell
LSE
GKP
Gulf Keystone Petroleum
LSE
TW.
Taylor Wimpey
LSE
MIN
Minoan
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved